Literature DB >> 10688434

Different serum soluble Fas levels in patients with allergic rhinitis and bronchial asthma.

M Kato1, Y Nozaki, T Yoshimoto, Y Tamada, M Kageyama, T Yamashita, F Kurimoto, I Nakashima.   

Abstract

BACKGROUND: The pathogeneses of allergic rhinitis and bronchial asthma are believed to be closely mutually related because of the similar dynamics of allergy-inducing cells and molecules and clinical overlap. In this study, we compared these diseases in the dynamics of cell apoptosis-regulating molecules.
METHODS: Allergic rhinitis patients (n=36), bronchial asthma patients (n=22), and healthy subjects (n=32) were subjected to measurement of serum (soluble Fas) (sFas) levels during the stable and attack disease phases by a sandwich enzyme-linked immunosorbent assay.
RESULTS: Serum sFas levels in patients with allergic rhinitis during the attack phase were significantly lower (P<0.0001) than those in healthy individuals. There were no differences between them during the attack and stable disease phases. In contrast, serum sFas levels in patients with bronchial asthma during the attack phase were higher (P<0.0005) than those in healthy individuals. Interestingly, the levels during the attack phase were lower (P<0.002) than those during the stable phase.
CONCLUSIONS: Our results suggest a different pathogenesis for allergic rhinitis and bronchial asthma at the cell apoptosis-linked step.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10688434     DOI: 10.1034/j.1398-9995.1999.00303.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  6 in total

1.  Association of TLR-4 and TNF-alpha polymorphisms with clinical symptoms and cytokine levels in patients with allergic rhinitis.

Authors:  Magdolna Krasznai; Kinga Szaniszlo; Helga Kraxner; Eszter Vargha; Margit Kovacs; Zoltan Borocz; Edit Kaszas; Gyorgyi Mezei; Endre Cserhati; Karoly Cseh
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-11-20       Impact factor: 2.503

2.  Association of PPAR polymorphisms with cytokine levels in allergic rhinitis.

Authors:  Magdolna Krasznai; Kinga Szaniszlo; Helga Kraxner; Eszter Vargha; Margit Kovacs; Edit Kaszas; Gyorgyi Mezei; Endre Cserhati; Zoltan Borocz; Karoly Cseh
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-07-23       Impact factor: 2.503

3.  Soluble trail as a marker of efficacy of allergen-specific immunotherapy in patients with allergic rhinoconjunctivitis.

Authors:  Arzu Didem Yalcin; Saadet Gumuslu; Gizem Esra Parlak; Atil Bısgın
Journal:  Med Sci Monit       Date:  2012-10

4.  Serum-soluble TRAIL levels in patients with severe persistent allergic asthma: its relation to omalizumab treatment.

Authors:  Arzu Didem Yalcin; Atil Bisgin; Aysegul Kargi; Reginald M Gorczynski
Journal:  Med Sci Monit       Date:  2012-03

5.  Increased apoptosis of peripheral blood mononuclear cells in patients with perennial allergic asthma/rhinitis: relation to serum markers of apoptosis.

Authors:  Janina Grzegorczyk; Marek L Kowalski; Anna Pilat; Jolanta Iwaszkiewicz
Journal:  Mediators Inflamm       Date:  2002-08       Impact factor: 4.711

Review 6.  Multidisciplinary approach to assess the toxicities of arsenic and barium in drinking water.

Authors:  Masashi Kato; Nobutaka Ohgami; Shoko Ohnuma; Kazunori Hashimoto; Akira Tazaki; Huadong Xu; Lisa Kondo-Ida; Tian Yuan; Tomoyuki Tsuchiyama; Tingchao He; Fitri Kurniasari; Yishuo Gu; Wei Chen; Yuqi Deng; Kanako Komuro; Keming Tong; Ichiro Yajima
Journal:  Environ Health Prev Med       Date:  2020-05-27       Impact factor: 3.674

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.